Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK 4/6 inhibitor palbociclib
Teemu P. Miettinen, Julien Peltier, Anetta Härtlová, et al.
The EMBO Journal (2018) Vol. 37, Iss. 10
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Tareq Saleh, Sarah Bloukh, Valerie J. Carpenter, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 822-822
Open Access | Times Cited: 227
Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution
Massimiliano Gaetani, Pierre Sabatier, Amir Ata Saei, et al.
Journal of Proteome Research (2019) Vol. 18, Iss. 11, pp. 4027-4037
Open Access | Times Cited: 212
CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal
Lisa Crozier, Reece Foy, Brandon L. Mouery, et al.
The EMBO Journal (2022) Vol. 41, Iss. 6
Open Access | Times Cited: 86
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman, Sarah Alexandrou, Emma‐Kate Carson, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 1, pp. R15-R30
Open Access | Times Cited: 142
Recent advances in identifying protein targets in drug discovery
Jaeyoung Ha, Hankum Park, Jongmin Park, et al.
Cell chemical biology (2020) Vol. 28, Iss. 3, pp. 394-423
Open Access | Times Cited: 117
Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome
Jerzy M. Dziekan, Grennady Wirjanata, Lingyun Dai, et al.
Nature Protocols (2020) Vol. 15, Iss. 6, pp. 1881-1921
Closed Access | Times Cited: 116
Horizontal Cell Biology: Monitoring Global Changes of Protein Interaction States with the Proteome-Wide Cellular Thermal Shift Assay (CETSA)
Lingyun Dai, Nayana Prabhu, Liang Ying Yu, et al.
Annual Review of Biochemistry (2019) Vol. 88, Iss. 1, pp. 383-408
Closed Access | Times Cited: 105
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Verena Wagner, Jesús Gil
Oncogene (2020) Vol. 39, Iss. 29, pp. 5165-5176
Open Access | Times Cited: 102
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
А. В. Морозов, В. Л. Карпов
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 100
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins*
Dorothee Childs, Karsten Bach, Holger Franken, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 12, pp. 2506-2515
Open Access | Times Cited: 95
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
Mara Bonelli, Silvia La Monica, Claudia Fumarola, et al.
Biochemical Pharmacology (2019) Vol. 170, pp. 113676-113676
Closed Access | Times Cited: 86
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Francisco Triana-Martínez, Marı́a Isabel Loza, Eduardo Domínguez
Cells (2020) Vol. 9, Iss. 2, pp. 346-346
Open Access | Times Cited: 81
Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy
Zhiying Huang, Shu Gan, Xuerong Zhuang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2472-2472
Open Access | Times Cited: 63
Integration of Mass Spectrometry Data for Structural Biology
Hannah M. Britt, Tristan Cragnolini, Konstantinos Thalassinos
Chemical Reviews (2021) Vol. 122, Iss. 8, pp. 7952-7986
Open Access | Times Cited: 59
Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling
Amy L. George, Frances R. Sidgwick, Jessica E. Watt, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 8, pp. 2629-2640
Open Access | Times Cited: 26
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
Balbina García-Reyes, Anna-Laura Kretz, Jan-Philipp Ruff, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3219-3219
Open Access | Times Cited: 74
Lysosomal trapping of palbociclib and its functional implications
Susana Llanos, Diego Megı́as, Carmen Blanco‐Aparicio, et al.
Oncogene (2019) Vol. 38, Iss. 20, pp. 3886-3902
Open Access | Times Cited: 70
Functional heterogeneity in senescence
Kristina Kirschner, Nattaphong Rattanavirotkul, Megan F. Quince, et al.
Biochemical Society Transactions (2020) Vol. 48, Iss. 3, pp. 765-773
Open Access | Times Cited: 68
Selection of Heating Temperatures Improves the Sensitivity of the Proteome Integral Solubility Alteration Assay
Jiaming Li, Jonathan G. Van Vranken, João A. Paulo, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 5, pp. 2159-2166
Open Access | Times Cited: 55
Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
Mudasir Nabi Peerzada, Ernest Hamel, Ruoli Bai, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107860-107860
Closed Access | Times Cited: 54
Drug Target Identification in Tissues by Thermal Proteome Profiling
André Mateus, Nils Kurzawa, Jessica Perrin, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 465-482
Open Access | Times Cited: 52
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
Gian Luca Rampioni Vinciguerra, Maura Sonego, Ilenia Segatto, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Non-canonical pathway for Rb inactivation and external signaling coordinate cell-cycle entry without CDK4/6 activity
Mimi Zhang, Sungsoo Kim, Hee Won Yang
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Keiji Kurata, Mehmet Samur, Priscilla Liow, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 9, pp. 1807-1821
Open Access | Times Cited: 17
Mass spectrometry-based Cellular Thermal Shift Assay (CETSA®) for target deconvolution in phenotypic drug discovery
Tomas Friman
Bioorganic & Medicinal Chemistry (2019) Vol. 28, Iss. 1, pp. 115174-115174
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top